Sugi Predict

Sugi Predict / Compounds / SCHEMBL7751947

SCHEMBL7751947

SCHEMBL7751947

NCCCC[C@@H]([C]=O)NC(=O)[C@@H](N)CCCCN

nearest known ligand 0.50

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ DPP7 Q9UHL4 8/20 0.50
▸ DPP8 Q6V1X1 6/20 0.50
▸ DPP9 Q86TI2 5/20 0.50
▸ GSR P00390 1/20 0.48
▸ GNAI3 P08754 1/20 0.46
▸ GNAO1 P09471 1/20 0.46
▸ GNAI1 P63096 1/20 0.46
▸ DPP4 P27487 4/20 0.44
▸ MMP2 P08253 2/20 0.40
▸ TERT O14746 3/20 0.37
▸ TLR2 O60603 2/20 0.36
▸ LTA4H P09960 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7751944 1.00 DPP7 (0.50) DPP7DPP8DPP9GSRGNAI3
SCHEMBL10520841 0.92 DPP7 (0.62) DPP7DPP8DPP9GSRGNAI3
SCHEMBL8495681 0.91 DPP7 (0.56) DPP7DPP8DPP9GSRGNAI3
SCHEMBL1888867 0.89 FOLH1 (0.47) DPP7DPP8DPP9GSRGNAI3
SCHEMBL8567236 0.89 FOLH1 (0.47) DPP7DPP8DPP9GSRGNAI3
SCHEMBL1889778 0.89 DPP8 (0.47) DPP7DPP8DPP9GSRGNAI3
SCHEMBL6255972 0.89 DPP8 (0.47) DPP7DPP8DPP9GSRGNAI3
SCHEMBL6255984 0.89 DPP8 (0.47) DPP7DPP8DPP9GSRGNAI3
SCHEMBL2192330 0.89 DPP8 (0.45) DPP7DPP8DPP9GSRGNAI3
SCHEMBL2192260 0.89 DPP8 (0.47) DPP7DPP8DPP9GSRGNAI3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220175872-A1 THERMOGENIC COMPOSITIONS AND METHODS OHIO STATE INNOVATION FOUNDATION 2022-06-09 — — US claimed
US-10098967-B2 Self-assembly of therapeutic agent-peptide nanostructures OHIO STATE INNOVATION FOUNDATION (US) 2018-10-16 — — US claimed
US-20180185502-A1 IMMOBILIZATION OF BIOMOLECULES BY SELF-ASSEMBLED NANOSTRUCTURES OHIO STATE INNOVATION FOUNDATION 2018-07-05 — — US claimed
WO-2017172881-A1 THERMOGENIC COMPOSITIONS AND METHODS OHIO STATE INNOVATION FOUNDATION (US) 2017-10-05 — — WO claimed
WO-2016210141-A1 IMMOBILIZATION OF BIOMOLECULES BY SELF-ASSEMBLED NANOSTRUCTURES OHIO STATE INNOVATION FOUNDATION (US) 2016-12-29 — — WO claimed
US-20140155577-A1 SELF-ASSEMBLY OF THERAPEUTIC AGENT-PEPTIDE NANOSTRUCTURES OHIO STATE INNOVATION FOUNDATION (US) 2014-06-05 — — US claimed
US-4861755-A Peptides with vasorelaxant, natriuretic and diuretic effects a process for their preparation, agents containing them, and their use HOECHST AKTIENGESELLSCHAFT (DE) 1989-08-29 — — US claimed
CN-111902394-B Compositions and methods relating to salts of specific pro-inflammatory regressive mediators 西蒂斯制药有限责任公司 2024-03-08 — — CN disclosed
US-20220175872-A1 THERMOGENIC COMPOSITIONS AND METHODS OHIO STATE INNOVATION FOUNDATION 2022-06-09 — — US disclosed
CN-110041427-A Anti- hepcidin antibody and application thereof 本质生命科学有限公司 2019-07-23 — — CN disclosed
CN-105263514-B Anti-hepcidin antibodies and uses thereof 本质生命科学有限公司 2019-04-26 — — CN disclosed
US-20190083574-A1 THERMOGENIC COMPOSITIONS AND METHODS OHIO STATE INNOVATION FOUNDATION (US) 2019-03-21 — — US disclosed
CN-109069692-A COMPOSITION FOR TREATING INTERVERTEBRAL DISC 国立大学法人北海道大学 2018-12-21 — — CN disclosed
WO-1999050281-A2 COLLAGEN PEPTIDES AND USES THEREOF CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) 1999-10-07 — — WO disclosed
US-4861755-A Peptides with vasorelaxant, natriuretic and diuretic effects a process for their preparation, agents containing them, and their use HOECHST AKTIENGESELLSCHAFT (DE) 1989-08-29 — — US disclosed
US-4839175-A USING CHOLESTEROL DERIVATIVES; FOR OPTHALMIC DRUG DELIVERY LIPOSOME TECHNOLOGY, INC. (US) 1989-06-13 — — US disclosed
EP-0316345-A1 LIPOSOMES WITH ENHANCED RETENTION ON MUCOSAL TISSUE LIPOSOME TECHNOLOGY, INC. (US) 1989-05-24 — — EP disclosed
EP-0316345-A4 LIPOSOMES WITH ENHANCED RETENTION ON MUCOSAL TISSUE. LIPOSOME TECHNOLOGY INC (US) 1989-05-16 — — EP disclosed
US-4804539-A Ophthalmic liposomes LIPOSOME TECHNOLOGY, INC. (US) 1989-02-14 — — US disclosed
WO-1988000824-A1 LIPOSOMES WITH ENHANCED RETENTION ON MUCOSAL TISSUE LIPOSOME TECHNOLOGY, INC. (US) 1988-02-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180185502-A1 IMMOBILIZATION OF BIOMOLECULES BY SELF-ASSEMBLED NANOSTRUCTURES CA1, CPN1, CA7 DPP7 493/4885DPP8 275/4885DPP9 1839/4885
US-20220175872-A1 THERMOGENIC COMPOSITIONS AND METHODS LRBA, IAPP, FABP4 DPP7 57/4885DPP8 147/4885DPP9 95/4885
US-20140155577-A1 SELF-ASSEMBLY OF THERAPEUTIC AGENT-PEPTIDE NANOSTRUCTURES IAPP, TAP1, LNPEP DPP7 365/4885DPP8 449/4885DPP9 626/4885
US-10098967-B2 Self-assembly of therapeutic agent-peptide nanostructures IAPP, NPPA, TAP1 DPP7 162/4885DPP8 259/4885DPP9 525/4885
US-20190083574-A1 THERMOGENIC COMPOSITIONS AND METHODS LRBA, IAPP, FABP4 DPP7 57/4885DPP8 147/4885DPP9 95/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.